+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
Practical Cardiovascular Medicine. Edition No. 2 - Product Thumbnail Image

Practical Cardiovascular Medicine. Edition No. 2

  • Book
  • March 2022
  • 992 Pages
Handbook of Venous Thromboembolism. Edition No. 1 - Product Thumbnail Image

Handbook of Venous Thromboembolism. Edition No. 1

  • Book
  • January 2018
  • 344 Pages
Pediatric Cardiovascular Medicine. Edition No. 2 - Product Thumbnail Image

Pediatric Cardiovascular Medicine. Edition No. 2

  • Book
  • February 2012
  • 1096 Pages
Management of Heart Failure. Edition No. 1 - Product Thumbnail Image

Management of Heart Failure. Edition No. 1

  • Book
  • October 2010
  • 408 Pages
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more